FluidForm to Develop New 3D Bioprinting Solutions for J&J Bioprinting

FluidForm to Develop New 3D Bioprinting Solutions for J&J Bioprinting

FluidForm, an expert in the field of human tissue for research, repair, and replacement signed an agreement with Ethicon, a member of the Johnson & Johnson Medical Devices Companies, to develop 3D bioprinted applications using FluidForm’s patented FRESH technology. This collaboration leverages FluidForm’s FRESH 3D bioprinting platform to achieve specific tissue characteristics that cannot be manufactured with conventional techniques.